Matteo Zanda
5Patents
2h-index
20Co-inventors
47Inventor score
Filing activity: Sep 23, 2002 → Aug 26, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8580820B2 | Tubulysin compounds with high cytotoxicity, pharmaceutical compositions thereof, and method of use thereof | Chemistry; Metallurgy | 36 | Active |
| US7361668B2 | Quinuclidine derivatives processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors | Human Necessities | 6 | Expired |
| US10377711B2 | Cannabinoid type 1 receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US7999101B2 | Cationic lipids for the transfection of nucleic acids | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9181196B2 | Pharmaceutical compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.